Companies/EU/MOB

Moberg Pharma AB (publ)

Income flow

Annual
MOB ANNUAL Income StatementPeriod 2024-12-31Source ANNUAL
MOB-015SEK 10MRevenueSEK 10MGross profitSEK 6MCost of revenueSEK 3M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2024-12-31 · ANNUAL · SEK
By activity
By activitySEK 10M
  • MOB-015SEK 10M100.0%
By geography
By geographySEK 10M
  • EuropeSEK 10M100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).47.2MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).37.7M
Dividend calendar
Ex-dividend
2019-11-04
Last cash
264.7042 · 2019-11-04
Stock splits
  1. 1:102023-05-24